AXT Inc (AXTI) director sells 4,000 shares in August trade
Rhea-AI Filing Summary
AXT INC (AXTI) director Leonard J. LeBlanc reported selling 4,000 shares of common stock on 2026-08-17 in an open-market or private sale at $96.0701 per share. Following this transaction, he directly holds 113,129 shares of AXT INC common stock. The filing’s Rule 10b5-1 checkbox is not marked as affirming a trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,000 shares
Net Sell
1 txn
Insider
LEBLANC LEONARD J
Role
Director
Sold
4,000 shs ($384K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,000 | $96.0701 | $384K |
Holdings After Transaction:
Common Stock — 113,129 shares (Direct)
Key Figures
Shares sold: 4,000 shares
Sale price per share: $96.0701 per share
Shares owned after transaction: 113,129 shares
+2 more
5 metrics
Shares sold
4,000 shares
Common Stock sold by director Leonard J. LeBlanc on 2026-08-17
Sale price per share
$96.0701 per share
Price for 4,000 AXTI common shares sold on 2026-08-17
Shares owned after transaction
113,129 shares
Direct holdings of AXTI common stock by Leonard J. LeBlanc after sale
Net shares sold in filing
4,000 shares
Net sell volume across all reported transactions in this Form 4
Number of sale transactions
1 transaction
Single non-derivative sale reported for AXTI common stock
Key Terms
Form 4, non-derivative, Rule 10b5-1
3 terms
Form 4 regulatory
"Leonard J. LeBlanc directly owns 113,129 AXTI shares as disclosed in the Form 4"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
non-derivative financial
"The sale was classified as a non-derivative transaction in common stock"
Rule 10b5-1 regulatory
"The filing’s Rule 10b5-1 checkbox is not marked as affirming a trading plan"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What insider transaction did AXTI director Leonard J. LeBlanc report?
Leonard J. LeBlanc reported selling 4,000 AXTI shares of common stock on 2026-08-17. The sale was coded as an open-market or private transaction at a per-share price of $96.0701.
Is the August 17, 2026 AXTI insider sale under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not checked as affirming a trading plan. This indicates the sale of 4,000 AXTI shares was not affirmatively reported as executed under a Rule 10b5-1 trading arrangement.
What is the transaction code used for the AXTI insider sale on August 17, 2026?
The transaction uses code S, which denotes a sale in an open market or private transaction. It involves 4,000 AXTI common shares and is classified as a non-derivative transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.